Jeffrey Hill, APRN
Psychiatric/Mental Health · Prairie Village, KSNPI 1073826962
Payments from drug & device makers
Across 81 payments — averaging $45.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Otsuka America Pharmaceutical, Inc.$780
- Axsome Therapeutics, Inc.$615
- Tris Pharma Inc$490
- AbbVie$310
- Teva Pharmaceuticals USA, Inc.$281
- Alkermes, Inc.$152
- plus $1K from 15 others
What the payments were for
- Food & beverage$3,724100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 15 | $780 |
| Axsome Therapeutics, Inc. | 10 | $615 |
| Tris Pharma Inc | 10 | $490 |
| AbbVie | 6 | $310 |
| Teva Pharmaceuticals USA, Inc. | 10 | $281 |
| Alkermes, Inc. | 3 | $152 |
| Neurocrine Biosciences, Inc. | 3 | $151 |
| Amgen | 1 | $129 |
| AstraZeneca | 1 | $127 |
| Supernus Pharmaceuticals, Inc. | 1 | $117 |
| Collegium Pharmaceutical, Inc. | 1 | $117 |
| Vanda Pharmaceuticals Inc. | 5 | $109 |
| E.r. Squibb & Sons, L.L.C. | 1 | $99 |
| Corium, LLC | 3 | $59 |
| Johnson & Johnson | 3 | $44 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $39 |
| Noven Therapeutics, LLC | 2 | $32 |
| Boston Scientific | 1 | $22 |
| Chiesi USA, Inc. | 1 | $21 |
| Acadia Pharmaceuticals Inc | 1 | $16 |
| Neos Therapeutics, LP | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LYBALVI$433
- Quillichew ER$368
- Dyanavel XR$368
- Quillivant$368
- REXULTI$256
- VRAYLAR$242
- ABILIFY ASIMTUFII$233
- ABILIFY MAINTENA$233
- TEZSPIRE$129
- WAINUA$127
- UZEDY$125
- SUNOSI$122
- Auvelity$121
- QELBREE$117
- JORNAY PM$117
- INGREZZA$108
- Austedo XR$106
How this compares
$3,724 in reported general payments places this provider in the 85th percentile of 404 psychiatric/mental health providers in Kansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Vilazodone Hcl | 11 | $870 |
| Quetiapine Fumarate | 13 | $651 |
| Trazodone Hcl | 31 | $543 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 11 | $391 |
| Memantine Hcl | 23 | $288 |
| Divalproex Sodium ErDivalproex Sodium | 13 | $251 |
| Clonazepam | 23 | $142 |
| Propranolol Hcl | 13 | $140 |
| Lamotrigine | 17 | $82 |
| Fluoxetine Hcl | 11 | $71 |
| Alprazolam | 12 | $36 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Prairie Village
- Eric ThomasonPittsburg$333K
- Belinda BagbyHutchinson$39K
- Hayley KnappWichita$31K
- Jennifer KubinBaldwin City$26K
- Uyen DinhPittsburg$20K
- Louise MuhoziKansas City$14K
- Theresa MuellerOverland Park$14K
- Shiney ZchariaOlathe$14K
- Deborah MurphyWichita$13K
- Marijen AgaShawnee$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.